7/20/07 Update
The plunge in GPCB & SPPI following the satraplatin debacle capped off a lousy week for small-cap biotechs. At Friday's close, the Nasdaq Biotech Index was up 2.17% YTD (vs. up 3.59% YTD a week ago), while the median for the Charity Contest portfolios was now down -2.92% YTD (vs. down -.89%% YTD a week ago).
At week's end, 12 of the 31 Contest portfolios were in the black YTD with 11 of 31 beating the NBI.
RCMAC remains in first place with a 32.5% YTD gain, but his lead was substantially narrowed by ICEBERG who now sports a 30.0% YTD gain.
Below is the Top Ten list on 7/20/07:
7/20/07
Rank Name Total
1 RCMAC 32,491
2 ICEBERG 30,028
3 FRED 21,261
4 FILOF 14,098
5 BIOFISH 13,263
6 ROBERT 12,369
7 MOPGCW 11,168
8 TECHNET 10,531
9 MANNY 10,360
10 WILDER 9,458
(All corrections greatly appreciated.) |
